Solara Active Pharma Sciences Limited (NSE:SOLARA) — Stock Price

Rs514.20 INR
▲ 2.31% today

Solara Active Pharma Sciences Limited (NSE:SOLARA) is currently trading at Rs514.20 INR, up 2.31% today. Over the past 52 weeks, shares have ranged between Rs425.55 and Rs686.50. This page tracks Solara Active Pharma Sciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Solara Active Pharma Sciences Limited (SOLARA) total market value.

Solara Active Pharma Sciences Limited (SOLARA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Solara Active Pharma Sciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Solara Active Pharma Sciences Limited Income Statement — Revenue, Profit & Earnings by Year

Solara Active Pharma Sciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs12.84 Billion Rs12.89 Billion Rs14.27 Billion Rs12.68 Billion Rs15.97 Billion
Cost of Revenue Rs6.26 Billion Rs14.04 Billion Rs13.02 Billion Rs7.08 Billion Rs12.16 Billion
Gross Profit Rs6.57 Billion Rs-1.30 Billion Rs1.25 Billion Rs5.60 Billion Rs3.81 Billion
Research & Development Rs344.80 Million Rs559.80 Million Rs461.60 Million Rs656.20 Million Rs529.10 Million
SG&A Rs2.14 Billion Rs243.30 Million Rs2.30 Billion Rs2.39 Billion Rs328.50 Million
Total Operating Expenses Rs2.12 Billion Rs2.55 Billion Rs1.16 Billion Rs1.34 Billion Rs1.19 Billion
Operating Income Rs4.46 Billion Rs-3.85 Billion Rs85.60 Million Rs-332.80 Million Rs2.62 Billion
EBITDA Rs2.06 Billion Rs-2.82 Billion Rs1.52 Billion Rs793.30 Million Rs4.14 Billion
EBIT Rs1.07 Billion Rs-3.85 Billion Rs418.20 Million Rs-259.90 Million Rs3.06 Billion
Interest Expense Rs1.15 Billion Rs1.04 Billion Rs866.40 Million Rs698.00 Million Rs843.70 Million
Income Before Tax Rs5.40 Million Rs-4.88 Billion Rs-448.10 Million Rs-911.00 Million Rs2.21 Billion
Income Tax Expense — Rs785.40 Million Rs-225.70 Million Rs-328.10 Million Rs1.50 Million
Net Income Rs5.40 Million Rs-5.67 Billion Rs-221.70 Million Rs-581.50 Million Rs2.21 Billion

Solara Active Pharma Sciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Solara Active Pharma Sciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs22.32 Billion Rs23.51 Billion Rs28.99 Billion Rs29.53 Billion Rs26.14 Billion
Total Current Assets Rs7.29 Billion Rs8.01 Billion Rs11.87 Billion Rs12.39 Billion Rs10.58 Billion
Cash & Equivalents Rs39.50 Million — Rs87.30 Million Rs424.70 Million Rs1.94 Billion
Short-term Investments Rs125.20 Million Rs75.80 Million Rs133.90 Million Rs104.00 Million Rs286.20 Million
Net Receivables Rs3.27 Billion Rs3.49 Billion Rs5.37 Billion Rs4.90 Billion Rs4.84 Billion
Inventory Rs3.18 Billion Rs3.60 Billion Rs5.58 Billion Rs5.76 Billion Rs2.95 Billion
Property, Plant & Equipment Rs10.76 Billion Rs11.14 Billion Rs11.59 Billion Rs11.37 Billion Rs9.99 Billion
Goodwill Rs3.65 Billion Rs3.65 Billion Rs3.65 Billion Rs3.65 Billion Rs3.65 Billion
Total Liabilities Rs11.35 Billion Rs14.14 Billion Rs13.97 Billion Rs14.18 Billion Rs10.21 Billion
Total Current Liabilities Rs9.44 Billion Rs12.43 Billion Rs11.01 Billion Rs10.63 Billion Rs7.89 Billion
Long-term Debt Rs1.14 Billion Rs1.06 Billion Rs2.35 Billion Rs2.83 Billion Rs1.55 Billion
Net Debt Rs7.92 Billion Rs10.03 Billion Rs10.04 Billion Rs9.91 Billion Rs4.23 Billion
Total Stockholder Equity Rs10.94 Billion Rs9.34 Billion Rs15.00 Billion Rs15.25 Billion Rs15.89 Billion
Retained Earnings Rs-3.16 Billion Rs-3.18 Billion Rs2.49 Billion Rs2.74 Billion Rs3.39 Billion

Solara Active Pharma Sciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Solara Active Pharma Sciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs2.13 Billion Rs1.09 Billion Rs1.56 Billion Rs-2.42 Billion Rs1.55 Billion
Capital Expenditures Rs399.40 Million Rs410.60 Million Rs1.11 Billion Rs2.09 Billion Rs1.74 Billion
Free Cash Flow Rs1.73 Billion Rs678.10 Million Rs449.40 Million Rs-4.51 Billion Rs-190.20 Million
Investing Cash Flow Rs-368.30 Million Rs-35.10 Million Rs-811.40 Million Rs-2.43 Billion Rs-1.06 Billion
Financing Cash Flow Rs-1.80 Billion Rs-1.06 Billion Rs-1.13 Billion Rs3.34 Billion Rs924.90 Million
Dividends Paid — — Rs0.00 Rs107.80 Million Rs197.30 Million
Stock-Based Compensation Rs26.80 Million Rs6.00 Million Rs500.00K Rs-13.10 Million Rs51.40 Million
Depreciation Rs992.50 Million Rs1.03 Billion Rs1.11 Billion Rs1.12 Billion Rs1.09 Billion
Change in Cash Rs-44.90 Million Rs-2.90 Million Rs-376.50 Million Rs-1.51 Billion Rs1.42 Billion

Solara Active Pharma Sciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Solara Active Pharma Sciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 13, 2026 — — —
Jan 22, 2026 — — —
Oct 20, 2025 — — —
Jul 21, 2025 — — —
May 15, 2025 — — —
Feb 12, 2025 — — —
Nov 14, 2023 0.12 -1.00 +112.00%
Aug 14, 2023 0.12 -1.00 +112.00%